Bixiye
QP20-26 Commercial and MHCP Pharmacy Benefit Update: New and Revised Drug-Related Prior Authorization (PA) Requirement Notification, Effective May 1, 2026
Taariikhda uu dhaqangalayo Barnaamijka: Mar 11, 2026
Natiijooyinka Raadinta
Soo bandhiga 4081 - 4090 ee natiijooyinka 4226
Bixiye
QP19-26 Commercial Pharmacy Benefit Exclusion for Select Medications
Taariikhda uu dhaqangalayo Barnaamijka: Mar 11, 2026
Bixiye
QP18-26 MHCP Pharmacy Benefit Exclusion for Lunsumio Velo™ and Yartemlea™
Taariikhda uu dhaqangalayo Barnaamijka: Mar 11, 2026
Bixiye
QP17-26 Commercial Pharmacy Benefit Exclusion for Yartemlea™
Taariikhda uu dhaqangalayo Barnaamijka: Mar 11, 2026
Bixiye
QP16-26 Diabetic Supplies for Medicare Subscribers
Taariikhda uu dhaqangalayo Barnaamijka: Mar 11, 2026
Bixiye
QP15-26 Provider Press: Q1 2026
Taariikhda uu dhaqangalayo Barnaamijka: Mar 11, 2026
Bixiye
QP14-26 Early Intensive Developmental and Behavioral Intervention (EIDBI) Qualified Supervising Professional (QSP) Requirements
Taariikhda uu dhaqangalayo Barnaamijka: Mar 11, 2026
Bixiye
QP13-26 Early Intensive Developmental and Behavioral Intervention (EIDBI) Provisional License
Taariikhda uu dhaqangalayo Barnaamijka: Mar 11, 2026